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OBJECTIVE The goal of the study was to determine whether microbubble charge influences the
microvascular retention of microbubble contrast agents.
BACKGROUND Interactions between serum proteins and lipid membranes are greater with anionic compared
with neutral membranes. These interactions may influence the microvascular behavior of
anionic lipid microbubbles.
METHODS Intravital microscopy of the cremaster muscle was performed in six wild-type mice and three
C3-deficient mice during intravenous injection of lipid-shelled microbubbles with either a
neutral or a negative charge. Both agents were prepared with and without a protective surface
layer of polyethyleneglycol (PEG). Complement attachment to microbubbles was assessed by
flow cytometry with flourescein isothiocyanate-conjugated anti-C3b monoclonal antibody.
Myocardial contrast echocardiography was performed in six dogs to assess pulmonary and
myocardial retention of microbubbles.
RESULTS Size-independent capillary retention of microbubbles, occurring for a few seconds to 10
min, was frequently observed with anionic, but rarely with neutral, microbubbles (4.3  0.3
vs. 0.4  0.1 mm3, p  0.01). Anionic microbubble retention was reduced by 70% by
surface PEG and was also markedly reduced in C3-deficient mice (1.4 0.1 mm3, p 0.05
vs. wild-type). Flow cytometry demonstrated complement attachment to only anionic
microbubbles. Contrast echocardiography indicated both pulmonary and myocardial reten-
tion of only anionic microbubbles, the latter evidenced by persistent opacification 10 min
after bolus intravenous injection.
CONCLUSIONS Lipid microbubbles with a net negative charge can be retained within capillaries via
complement-mediated attachment to endothelium. This property may be useful for the
development of ultrasound contrast agents that can be imaged late after venous
injection. (J Am Coll Cardiol 2002;40:811–9) © 2002 by the American College of
Cardiology Foundation
Most of the current microbubble ultrasound contrast agents
have an intravascular rheology similar to that of red blood
cells (1–3). Certain microbubble agents can adhere to
activated leukocytes in postcapillary venules via cell-surface
integrins or opsonization with complement, resulting in
persistent myocardial opacification in regions of tissue
inflammation (4,5). More recently, newer microbubble
preparations have been shown to produce persistent opaci-
fication in the absence of inflammation despite the small
size of the microbubbles (6). Myocardial persistence of these
microbubbles appears to be due to capillary, rather than
venular, retention (6).
A unique feature of one of the microbubble contrast
agents that is retained within the capillaries is the negative
charge on their lipid shells. Certain anionic lipids in the
membranes of liposomes have been shown to activate
complement and to enhance surface attachment of comple-
ment fragments and other plasma proteins (7–9). In this
study we hypothesized that lipid microbubbles with a net
negative charge (MBneg) are retained in normal tissue due to
complement-mediated interaction with the capillary endo-
thelium. Because the presence of polyethyleneglycol (PEG)
on the surface of lipid membranes may inhibit protein
attachment (10,11), we also assessed the influence of a
surface PEG layer on the microvascular behavior of these
microbubbles.
METHODS
Microbubble preparation. To assess the effect of charge
and the presence of a surface PEG layer on the behavior of
microbubble contrast agents, four different lipid micro-
bubble preparations were formulated: those with a neutral
(MBneut) or a net negative (MBneg) surface charge, each
with or without a surface PEG layer (PEG or PEG). For
MBneut, decafluorobutane gas was sonicated with an aque-
ous dispersion of 1.6 mg·ml1 distearoyl phosphatidylcho-
line (Avanti Polar Lipids, Alabaster, Alabama) and PEG-
5000, which was used to facilitate bubble formation. For
MBneg, 0.8 mg·ml
1 of dipalmitoyl phosphatidylglycerol
(Avanti Polar Lipids) was added to the dispersion. For
microbubbles with a protective surface PEG layer, 0.8
mg·ml1 PEG-40 stearate (Sigma, St. Louis, Missouri) was
added to the dispersion before sonication. For microscopy
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studies, microbubbles were fluorescently labeled with 0.025
mg·ml1 dioctadecyl-oxacarbocyanine (DiO, Molecular
Probes, Eugene, Oregon). All microbubbles were washed,
and their concentration and size distribution were deter-
mined by electrozone sensing with a Coulter Multisizer IIe
(Beckman-Coulter, Fullerton, California).
Microbubble charge was determined by their zeta poten-
tial measured by laser Doppler velocimetry (Zetaplus,
Brookhaven Instruments, Holtsville, New York) (12) of
approximately 1  107 microbubbles dispersed in 1 mM
KCl. Results of two separate measurements were averaged.
Complement attachment to microbubbles. Flow cytom-
etry of microbubbles was performed to determine whether
charge and the presence of PEG influenced serum comple-
ment attachment to the microbubble surface. For each
preparation 1  107 microbubbles were combined with 500
l of human serum for 5 min at 37°C and washed twice.
Aliquots of 2 106 serum-exposed or control microbubbles
were combined with a fluorescein isothiocyanate (FITC)-
labeled murine antihuman C3b monoclonal antibody
(mAb) (3E7) or an FITC-labeled IgG1 isotype-control
antibody for 10 min. Microbubbles were washed and ana-
lyzed on a FACSCalibur (Becton Dickinson, Franklin
Lakes, New Jersey) to generate histograms of green fluores-
cent intensity.
Intravital microscopy. The study was approved by the
Animal Research Committee at the University of Virginia.
Intravital microscopy was performed to assess the microvas-
cular behavior of the four microbubble preparations in the
normal circulation of nine male wild-type C57BL/6 mice
and three male C3-deficient (C3/) mice (B6.1229S4-
C3, Jackson Laboratory, Bar Harbor, Maine). The mice
were anesthetized with an intraperitoneal injection of a
solution containing ketamine hydrochloride, xylazine and
atropine. A cremaster muscle was exteriorized, prepared for
intravital microscopy, and superfused continuously with
isothermic bicarbonate-buffered saline. Observations were
made with an Axioskop2-FS microscope (Carl Zeiss, Inc.,
Thornwood, New York) with a saline-immersion objective
(20/0.5 N.A.) under combined transillumination and
fluorescent epi-illumination (469–500 nm excitation filter).
Video recordings were made with a high-resolution CCD
camera (C2400, Hamamatsu Photonics, Hamamatsu, Ja-
pan) that was interfaced with a video time display unit
(VTG-33 for A Ltd., Tokyo, Japan) and connected to an
S-VHS recorder (S9500, JVC, Elmwood Park, New Jersey).
For each microbubble type, 3  107 of DiO-labeled
microbubbles were injected via the jugular vein in random
order separated by 20-min intervals. Twenty optical fields
(total tissue volume 4.2  103 cm3) were observed 2 min,
6 min, and 12 min after each injection. Static microbubbles
were defined as those that were stationary for 3 s. After
each injection, randomly selected arterioles were recorded,
and velocity was measured with a dual-slit photodiode
(CircuSoft Instrumentation, Hockessin, Delaware) for cal-
culation of arteriolar blood flow and shear rate. The diam-
eter of retained microbubbles was measured off-line using
video calipers.
Contrast echocardiography. Contrast echocardiography
was performed to estimate the relative entrapment of
microbubbles in the pulmonary as well as the myocardial
microcirculation after intravenous bolus injection of the
different microbubble agents. Six anesthetized, open-chest
dogs were used for this purpose. Power-pulse inversion
imaging was performed with an HDI-5000 system (Philips
Ultrasound, Bothell, Washington) in the basal short-axis
plane using a saline bath as an acoustic interface. A
mechanical index of 0.1 and a pulse-repetition frequency of
2,500 Hz were used. Gain settings were optimized at the
beginning of each experiment and held constant. Images
were saved on magneto-optical disk and analyzed off-line
(HDI Lab, Philips Ultrasound).
To determine their pulmonary retention, 2  106 micro-
bubbles (either MBneutPEG
 or MBnegPEG
) were in-
jected as an intravenous bolus during acquisition of end-
diastolic frames at every one cardiac cycle. Video intensity
(VI) in the right ventricular (RV) and left ventricular (LV)
cavities was measured, and time-intensity data were fit to a
-variate function: y  Atet, where y is the VI at time t,
A is a scaling factor and  reflects the mean transit rate (13).
The integral for each time-intensity curve was calculated by
A/2 to represent the total number of microbubbles tran-
siting through each cavity (14). A pulmonary retention
index was calculated by the ratio of the LV to RV integrals.
End-diastolic and end-systolic RV short-axis dimensions
were measured by video calipers immediately before and 1
min after injection.
To assess their myocardial retention, 1  109 micro-
bubbles were injected as an intravenous bolus, and end-
systolic frames were acquired. In order to minimize micro-
bubble destruction, imaging was performed every one
cardiac cycle for 1 min and every 20 cardiac cycles thereafter.
Ten minutes after injection, VI was measured from the
anterior myocardium. The absence of signal from freely
circulating microbubbles was verified by the absence of
myocardial opacification from microbubble replenishment
after a brief sequence of high-power (mechanical index 1.1)
pulses.
Abbreviations and Acronyms
C3/ C3-deficient
FITC  fluorescein isothiocyanate
LV  left ventricular
mAb  monoclonal antibody
MBneg  lipid microbubbles with a net negative charge
MBneut  lipid microbubbles with a net neutral charge
PEG  polyetheleneglycol
PEG  without a surface polyetheleneglycol layer
PEG  with a surface polyetheleneglycol layer
RV  right ventricular
VI  video intensity
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Microbubble acoustic signal. In vitro experiments were
performed to determine whether the presence of PEG
influenced the acoustic signal from microbubbles. Either
MBneutPEG
 or MBneutPEG
 (5  107) was added to a
500-ml saline bath containing a magnetic stir bar. Measure-
ments of acoustic intensity were made using identical
settings used in the clinical experiments from a 2 cm2
region-of-interest at a depth of 5 to 7 cm. Measurements
were made 30 s after addition of microbubbles. Three
separate measurements were averaged for each agent.
Statistical methods. Data are expressed as the mean 
SD. Comparisons of continuous variables were made using
the Student t test (paired) and repeated-measures analysis of
variance. Categorical values of microbubble diameter were
compared by chi-square. Differences were considered sig-
nificant at p  0.05.
RESULTS
Microbubble size, charge, and microvascular behavior.
The mean microbubble size before injection was similar for
the four different microbubble preparations (Table 1). The
zeta potential, reflecting microbubble surface charge, was
highly negative for MBneg and was not substantially altered
by a surface PEG layer (Table 1). Microvascular flow and
shear rates in the cremasteric vessels were similar after
injection of the different microbubble preparations. In
wild-type mice, retention of MBneut in the cremaster was
uncommon, regardless of the presence or absence of PEG
(Fig. 1). In comparison, MBneg retention was much more
frequent, although it was substantially reduced (by 70%)
by the presence of PEG. In C3/ mice, MBneg retention
was markedly reduced compared with wild-type mice,
regardless of the presence or absence of PEG, and was
similar in extent to that for MBneut (Fig. 1). Microbubbles
were retained exclusively in capillaries or very small arte-
rioles (10 m).
The sizes of MBnegPEG
 and MBneutPEG
 were sim-
ilar before injection (Fig. 2A). Microbubbles that were
retained within the cremasteric microcirculation tended to
be large, although the diameters for retained MBnegPEG

were smaller than MBneutPEG
 (Fig. 2B). The infrequent
retention of MBneutPEG
 invariably resulted in cessation of
capillary flow. Retention of MBnegPEG
 was occasionally
associated with residual flux of RBCs around static micro-
bubbles, suggesting that microbubble size was not the sole
mechanism for MBnegPEG
 retention.
The duration of capillary retention varied from several
seconds to 10 min for individual microbubbles. Capillary
retention tended to decrease over time, although this was
significant only for MBnegPEG
 (4.3  0.3, 2.9  0.5, and
Table 1. Size and Charge Characteristics for Microbubbles
MBneutPEG
 MBneutPEG
 MBnegPEG
 MBnegPEG

Mean diameter (m)* 2.3  0.3 2.8  0.5 2.6  0.3 2.7  0.4
Zeta potential (mV) 3 1 73 69
*Analysis of variance, p  NS.
MBneg  lipid microbubbles with a net negative charge; MBneut  lipid microbubbles with a net neural charge; PEG 
polyetheleneglycol.
Figure 1. Mean ( SEM) number of microbubbles retained within the cremasteric microcirculation of wild-type and C3-deficient (C3/) mice after
injection of 3 107 microbubbles. *p 0.01 all other microbubbles in wild-type mice; †p 0.01 vs. MBneg in wild-type mice. MBneg lipid microbubbles
with a net negative charge; MBneut  lipid microbubbles with a net neutral charge; PEG  polyetheleneglycol.
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2.1 0.9 mm3 at 2, 6, and 12 min, respectively, p 0.05).
The time-dependent decrease in retention was due mostly
to gradual reduction in the frequency of brief static events.
Complement deposition on microbubble shell. Serum
complement attachment to microbubble shells was assessed
by flow cytometry. Figure 3 illustrates examples of flow
cytometry data for MBneutPEG
 (Fig. 3A) and
MBnegPEG
 (Fig. 3B) representing the two extremes with
respect to capillary retention. Histograms of green fluores-
cent intensity are shown for microbubbles incubated with
serum and FITC-conjugated control mAb (curve A), with
FITC-conjugated anti-C3b mAb alone without serum
(curve B), or with serum and FITC-conjugated anti-C3b
mAb (curve C). Fluorescent intensity for MBneutPEG

exposed to serum and FITC-conjugated anti-C3b mAb was
very low and was similar to that found for control experi-
ments. Fluorescent intensity for MBnegPEG
 exposed to
serum and FITC-conjugated anti-C3b mAb was much
greater than corresponding control experiments, indicating
attachment of C3b to the surface of these microbubbles.
Surface attachment of C3b, reflected by microbubble mean
fluorescent intensity, was much greater for MBneg compared
with MBneut, and was minimally inhibited by the presence
of PEG on the surface (Fig. 4). The mean fluorescent
intensity was low (50 U) for all control experiments.
Pulmonary and myocardial retention of microbubbles.
In vitro imaging experiments demonstrated similar VI for
equal concentrations of MBneutPEG
 and MBneutPEG

(37  2 vs. 35  3, p  0.51). These data indicate that the
surface layer of PEG produced minimal viscoelastic and
acoustic damping. Examples of time-intensity curves from
LV and RV cavities after a venous bolus injection of
microbubbles are shown in Figure 5. The area under the
curve for the LV relative to the RV was smaller for
MBnegPEG
 (panel B) compared with MBneutPEG
 (pan-
el A), indicating greater pulmonary retention for the latter.
These differences were quantified by the LV:RV integral of
the curves, which was significantly smaller for MBnegPEG

compared with MBneutPEG
 (0.35 0.16 vs. 0.66 0.15,
p  0.001), indicating greater pulmonary retention for the
former. These findings also imply that the differences in
cremasteric retention in wild-type mice for neutral com-
pared with anionic microbubbles (Fig. 1) may have been
underestimated because fewer of the anionic microbubbles
Figure 2. Size distribution of all microbubbles before injection (A) and those retained within the microcirculation (B). MBneg  lipid microbubbles with
a net negative charge; MBneut  lipid microbubbles with a neutral charge; PEG  polyetheleneglycol.
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would be expected to reach the systemic microcirculation.
Microbubble injections did not produce any significant
change in RV dimensions, even for MBnegPEG
 (5 5%
and 5  9% for changes in end-systolic and diastolic
diameters, p  0.40 and 0.61, respectively).
Figure 6 illustrates examples of myocardial time-intensity
curves obtained 10 min after intravenous injection of
MBneutPEG
 and MBnegPEG
 microbubbles, represent-
ing the two extremes for microbubble retention seen on
intravital microscopy. Persistent myocardial opacification
late after injection was seen only for MBnegPEG
. In all
animals myocardial contrast enhancement was detected 10
min after injection of MBnegPEG
 (background-subtracted
VI of 4  2 U) but was not seen for MBneutPEG

(background-subtracted VI of 1.0). As illustrated in Fig.
6, the presence of few residual circulating microbubbles was
verified for each experiment by lack of reappearance of
microbubble signal after a high-power pulse sequence that
destroyed retained microbubbles.
DISCUSSION
This is the first study to demonstrate that a net negative
shell charge can result in capillary retention of microbubbles
within the normal microcirculation via a mechanism other
than lodging, and that this effect can be substantially
reduced by the presence of a surface layer of PEG. We have
also demonstrated that retention is mediated by attachment
of activated C3b to the microbubble surface. Because this
property of microbubbles results in prolonged myocardial
opacification after a venous injection, modulating shell
surface charge may be an effective means of optimizing
microbubble kinetics for perfusion and viability imaging.
It has long been recognized that liposomes possessing a
net negative charge have a shorter intravascular lifespan
compared with their neutral counterparts due to
complement-mediated uptake by the reticuloendothelial
system (8,9). Accordingly, lipid-shelled microbubble con-
trast agents have been composed mostly of lipids that
Figure 3. Examples of flow cytometry data for lipid microbubbles with a net neutral charge with polyetheleneglycol (MBneutPEG
) and lipid microbubbles
with a net negative charge without polyetheleneglycol (MBnegPEG
). Histograms of green fluorescent intensity are shown for microbubbles incubated
with serum and florescein isothiocyanate (FITC)-conjugated control monoclonal antibody (mAb) (A), with FITC-conjugated anti-C3b mAb alone without
serum (B), or with serum and FITC-conjugated anti-C3b mAb (C). Corresponding fluorescent microscopy images from c samples are shown at the bottom
(scale bars  5 m).
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Figure 4. Degree of C3b attachment to microbubbles, determined by mean fluorescent intensity (y-axis) measured by flow cytometry of microbubbles
incubated with serum and fluorescein isothiocyanate (FITC)-conjugated anti-C3b monoclonal antibody.
Figure 5. Examples of time versus VI curves for the right ventricular and left ventricular cavities after bolus intravenous injection of lipid microbubbles with
a net neutral charge polyetheleneglycol (MBneutPEG
) (A) and lipid microbubbles with a net negative charge polyetheleneglycol (MBnegPEG
) (B). See
text for details. LV  left ventricular; RV  right ventricular.
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possess a neutral charge at physiologic pH in order to
optimize their intravascular stability and prolong their
circulation times. There has been no evidence for sys-
temic microvascular retention of encapsulated micro-
bubble contrast agents until just recently when it was
determined that a small fraction of a negatively charged
lipid microbubble preparation could be retained in the
capillaries (6).
In the current study, we demonstrated late myocardial
contrast enhancement after injection of anionic micro-
bubbles at a time when freely circulating microbubbles had
been cleared from the blood pool. Direct observations of the
skeletal muscle microcirculation confirmed that late opaci-
fication was due to capillary retention from microbubble-
endothelial interactions rather than size-dependent entrap-
ment. By comparing the microbubble behavior in wild-type
and C3/ mice, we were able to determine that serum
complement was responsible for the attachment of anionic
microbubbles to the capillary endothelium. We have previ-
ously demonstrated that lipid microbubbles with a weak
negative charge can be retained within inflamed tissue due
to complement-mediated attachment to activated leuko-
cytes within venules (4). We have further shown that
increasing the negative charge by addition of phosphatidyl-
serine on the surface markedly enhances this process (5). In
the current study, lipid microbubbles with a much stronger
negative charge were studied in the absence of inflamma-
tion. Leukocyte retention was very rarely seen due to the
lack of leukocyte activation and adhesion in venules. Reten-
tion instead occurred primarily in capillaries. Although the
precise mechanism responsible for endothelial attachment
of these microbubbles is not known, it is likely that C3b
binds to either membrane-associated complement proteins
(CD46) or decay-accelerating factor (CD55). These pro-
teins are expressed on the endothelial surface and are known
to bind to C3b and convert it to the inactive C3bi (15,16).
Reasons for preferential capillary retention of microbubbles
include selective expression of C3b-binding proteins on the
capillary endothelium, lower shear forces and size-related
requirement for adequate surface area to support attach-
ment.
Although retention of MBnegPEG
 was markedly re-
duced in C3/ mice, some residual retention was ob-
served, the extent of which was similar to MBneut (with or
without PEG) retention in wild-type mice. The micro-
bubbles responsible for this “background” retention were
relatively large (4 m) and were likely entrapped because
of their size. These large microbubbles may have evaded
pulmonary capillary filtering due to a small degree of
pulmonary shunting that may allow few of the larger
microbubbles to arrive in the systemic circulation (17).
Alternatively, other serum proteins that attach to negatively
Figure 6. Representative myocardial contrast enhancement images and time versus VI data from the anterior myocardium of one dog acquired 10 min after
intravenous injections of lipid microbubbles with a net negative charge without polyetheleneglycol (MBnegPEG
) (solid circles) and lipid microbubbles with a net
neutral charge with polyetheleneglycol (MBneutPEG
) (open circles). Data are shown before and after a brief high-power ultrasound sequence (HPS).
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charged lipid surfaces, such as fibrinogen, fibronectin, and
apolipoproteins, may have contributed to residual retention
(18).
The presence of PEG on the surface of liposomes has
been shown to inhibit electrostatic and hydrophobic inter-
actions between serum proteins and lipid membranes
(10,11). Reduced complement deposition on the surface of
PEG-containing liposomes may be responsible for their
longer circulating times by inhibiting uptake by reticulen-
dothelial cells (19,20). Many of the lipid microbubbles in
clinical use possess a protective PEG layer on the shell
surface. In this study, incorporation of PEG into the lipid
shell inhibited capillary retention of anionic microbubbles
by approximately 70%. Yet flow cytometry revealed that
C3b attachment to negatively charged microbubbles was
only mildly inhibited by PEG. These results suggest that
PEG reduced microbubble-endothelial interactions by
steric hindrance (21). In other words, PEG did little to
prevent complement deposition on the lipid shell but,
instead, provided a barrier to complement binding to
endothelial cell-surface receptors.
Microvascular retention of microbubbles with a strong
negative charge raises questions regarding their safety.
Dodecafluoropentane emulsion, an ultrasound contrast
agent formerly used in the experimental setting, produced
excellent myocardial opacification after clearance from the
circulating blood pool (22). However, its safety was called
into question due to marked pulmonary retention (22,23),
which may have been aggravated by volume expansion of
this nonencapsulated agent. Our data suggests that size-
independent pulmonary retention of encapsulated micro-
bubbles after venous injection is enhanced by a negative
charge on the shell. The much lower signal for the LV
compared with RV seen for all microbubbles does not
necessarily indicate a large retention fraction in the lung.
Large microbubbles contribute disproportionately to the
total signal from microbubbles (24). Hence, pulmonary
retention of the few large (5 m) microbubbles would be
expected to result in a disproportionate large decrease in the
LV cavity signal. Nevertheless, even modest pulmonary
retention could interfere with pulmonary gas exchange,
especially in patients with lung disease.
Our initial investigation of the in vivo kinetics of highly
anionic microbubbles indicated that these agents could
provide information on myocardial perfusion when imaged
early after a bolus injection and on myocardial viability on
delayed imaging (6). For this type of clinical application, it
may be possible to modulate the net charge and PEG
content of lipid microbubbles to an ideal level where
myocardial opacification is optimal, yet systemic or pulmo-
nary toxicity are minimal. Charge optimization may also be
important because myocardial retention can be offset by less
recirculation caused by complement-mediated reticuloendo-
thelial uptake of highly charged microbubbles. In order to
achieve these goals, it will be necessary to determine the
exact mechanism whereby complement mediates the inter-
action between anionic microbubbles and capillary endothe-
lium. It will also be important to determine whether the
capillary retention of strongly anionic microbubbles is en-
hanced in settings where complement is activated systemi-
cally or locally. Nonetheless, our current results provide
insight into how interactions between ultrasound contrast
agents and serum proteins can affect their behavior in the
normal microcirculation.
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